Glioblastoma Multiforme Treatment (GBM) Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Glioblastoma Multiforme Treatment (GBM) in Global, including the following market information:
Global Glioblastoma Multiforme Treatment (GBM) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Glioblastoma Multiforme Treatment (GBM) market was valued at 564.1 million in 2021 and is projected to reach US$ 990.5 million by 2028, at a CAGR of 8.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glioblastoma Multiforme Treatment (GBM) include Merck, Teva Pharmaceutical, Arbor Pharmaceuticals, Sun Pharmaceutical and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glioblastoma Multiforme Treatment (GBM) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glioblastoma Multiforme Treatment (GBM) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Glioblastoma Multiforme Treatment (GBM) Market Segment Percentages, by Type, 2021 (%)
Global Glioblastoma Multiforme Treatment (GBM) Market Segment Percentages, by Application, 2021 (%)
Global Glioblastoma Multiforme Treatment (GBM) Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Glioblastoma Multiforme Treatment (GBM) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Glioblastoma Multiforme Treatment (GBM) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Glioblastoma Multiforme Treatment (GBM) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Glioblastoma Multiforme Treatment (GBM) market was valued at 564.1 million in 2021 and is projected to reach US$ 990.5 million by 2028, at a CAGR of 8.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glioblastoma Multiforme Treatment (GBM) include Merck, Teva Pharmaceutical, Arbor Pharmaceuticals, Sun Pharmaceutical and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glioblastoma Multiforme Treatment (GBM) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glioblastoma Multiforme Treatment (GBM) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Glioblastoma Multiforme Treatment (GBM) Market Segment Percentages, by Type, 2021 (%)
- Chemotherapy
- Radiotherapy
- Gene therapy
- Molecular biotechnology
Global Glioblastoma Multiforme Treatment (GBM) Market Segment Percentages, by Application, 2021 (%)
- Hospital & Clinic
- ASCs
- Others
Global Glioblastoma Multiforme Treatment (GBM) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Glioblastoma Multiforme Treatment (GBM) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Glioblastoma Multiforme Treatment (GBM) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck
- Teva Pharmaceutical
- Arbor Pharmaceuticals
- Sun Pharmaceutical
- Roche
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Glioblastoma Multiforme Treatment (GBM) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glioblastoma Multiforme Treatment (GBM) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GLIOBLASTOMA MULTIFORME TREATMENT (GBM) OVERALL MARKET SIZE
2.1 Global Glioblastoma Multiforme Treatment (GBM) Market Size: 2021 VS 2028
2.2 Global Glioblastoma Multiforme Treatment (GBM) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Glioblastoma Multiforme Treatment (GBM) Players in Global Market
3.2 Top Global Glioblastoma Multiforme Treatment (GBM) Companies Ranked by Revenue
3.3 Global Glioblastoma Multiforme Treatment (GBM) Revenue by Companies
3.4 Top 3 and Top 5 Glioblastoma Multiforme Treatment (GBM) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Glioblastoma Multiforme Treatment (GBM) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Glioblastoma Multiforme Treatment (GBM) Players in Global Market
3.6.1 List of Global Tier 1 Glioblastoma Multiforme Treatment (GBM) Companies
3.6.2 List of Global Tier 2 and Tier 3 Glioblastoma Multiforme Treatment (GBM) Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Glioblastoma Multiforme Treatment (GBM) Market Size Markets, 2021 & 2028
4.1.2 Chemotherapy
4.1.3 Radiotherapy
4.1.4 Gene therapy
4.1.5 Molecular biotechnology
4.2 By Type - Global Glioblastoma Multiforme Treatment (GBM) Revenue & Forecasts
4.2.1 By Type - Global Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2022
4.2.2 By Type - Global Glioblastoma Multiforme Treatment (GBM) Revenue, 2023-2028
4.2.3 By Type - Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Glioblastoma Multiforme Treatment (GBM) Market Size, 2021 & 2028
5.1.2 Hospital & Clinic
5.1.3 ASCs
5.1.4 Others
5.2 By Application - Global Glioblastoma Multiforme Treatment (GBM) Revenue & Forecasts
5.2.1 By Application - Global Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2022
5.2.2 By Application - Global Glioblastoma Multiforme Treatment (GBM) Revenue, 2023-2028
5.2.3 By Application - Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Glioblastoma Multiforme Treatment (GBM) Market Size, 2021 & 2028
6.2 By Region - Global Glioblastoma Multiforme Treatment (GBM) Revenue & Forecasts
6.2.1 By Region - Global Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2022
6.2.2 By Region - Global Glioblastoma Multiforme Treatment (GBM) Revenue, 2023-2028
6.2.3 By Region - Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2028
6.3.2 US Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.3.3 Canada Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.3.4 Mexico Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2028
6.4.2 Germany Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.4.3 France Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.4.4 U.K. Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.4.5 Italy Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.4.6 Russia Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.4.7 Nordic Countries Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.4.8 Benelux Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2028
6.5.2 China Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.5.3 Japan Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.5.4 South Korea Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.5.5 Southeast Asia Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.5.6 India Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2028
6.6.2 Brazil Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.6.3 Argentina Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2028
6.7.2 Turkey Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.7.3 Israel Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.7.4 Saudi Arabia Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.7.5 UAE Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Glioblastoma Multiforme Treatment (GBM) Major Product Offerings
7.1.4 Merck Glioblastoma Multiforme Treatment (GBM) Revenue in Global Market (2017-2022)
7.1.5 Merck Key News
7.2 Teva Pharmaceutical
7.2.1 Teva Pharmaceutical Corporate Summary
7.2.2 Teva Pharmaceutical Business Overview
7.2.3 Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Major Product Offerings
7.2.4 Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Revenue in Global Market (2017-2022)
7.2.5 Teva Pharmaceutical Key News
7.3 Arbor Pharmaceuticals
7.3.1 Arbor Pharmaceuticals Corporate Summary
7.3.2 Arbor Pharmaceuticals Business Overview
7.3.3 Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Major Product Offerings
7.3.4 Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Revenue in Global Market (2017-2022)
7.3.5 Arbor Pharmaceuticals Key News
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Corporate Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Major Product Offerings
7.4.4 Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Revenue in Global Market (2017-2022)
7.4.5 Sun Pharmaceutical Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Glioblastoma Multiforme Treatment (GBM) Major Product Offerings
7.5.4 Roche Glioblastoma Multiforme Treatment (GBM) Revenue in Global Market (2017-2022)
7.5.5 Roche Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Glioblastoma Multiforme Treatment (GBM) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glioblastoma Multiforme Treatment (GBM) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GLIOBLASTOMA MULTIFORME TREATMENT (GBM) OVERALL MARKET SIZE
2.1 Global Glioblastoma Multiforme Treatment (GBM) Market Size: 2021 VS 2028
2.2 Global Glioblastoma Multiforme Treatment (GBM) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Glioblastoma Multiforme Treatment (GBM) Players in Global Market
3.2 Top Global Glioblastoma Multiforme Treatment (GBM) Companies Ranked by Revenue
3.3 Global Glioblastoma Multiforme Treatment (GBM) Revenue by Companies
3.4 Top 3 and Top 5 Glioblastoma Multiforme Treatment (GBM) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Glioblastoma Multiforme Treatment (GBM) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Glioblastoma Multiforme Treatment (GBM) Players in Global Market
3.6.1 List of Global Tier 1 Glioblastoma Multiforme Treatment (GBM) Companies
3.6.2 List of Global Tier 2 and Tier 3 Glioblastoma Multiforme Treatment (GBM) Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Glioblastoma Multiforme Treatment (GBM) Market Size Markets, 2021 & 2028
4.1.2 Chemotherapy
4.1.3 Radiotherapy
4.1.4 Gene therapy
4.1.5 Molecular biotechnology
4.2 By Type - Global Glioblastoma Multiforme Treatment (GBM) Revenue & Forecasts
4.2.1 By Type - Global Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2022
4.2.2 By Type - Global Glioblastoma Multiforme Treatment (GBM) Revenue, 2023-2028
4.2.3 By Type - Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Glioblastoma Multiforme Treatment (GBM) Market Size, 2021 & 2028
5.1.2 Hospital & Clinic
5.1.3 ASCs
5.1.4 Others
5.2 By Application - Global Glioblastoma Multiforme Treatment (GBM) Revenue & Forecasts
5.2.1 By Application - Global Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2022
5.2.2 By Application - Global Glioblastoma Multiforme Treatment (GBM) Revenue, 2023-2028
5.2.3 By Application - Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Glioblastoma Multiforme Treatment (GBM) Market Size, 2021 & 2028
6.2 By Region - Global Glioblastoma Multiforme Treatment (GBM) Revenue & Forecasts
6.2.1 By Region - Global Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2022
6.2.2 By Region - Global Glioblastoma Multiforme Treatment (GBM) Revenue, 2023-2028
6.2.3 By Region - Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2028
6.3.2 US Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.3.3 Canada Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.3.4 Mexico Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2028
6.4.2 Germany Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.4.3 France Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.4.4 U.K. Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.4.5 Italy Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.4.6 Russia Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.4.7 Nordic Countries Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.4.8 Benelux Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2028
6.5.2 China Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.5.3 Japan Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.5.4 South Korea Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.5.5 Southeast Asia Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.5.6 India Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2028
6.6.2 Brazil Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.6.3 Argentina Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2028
6.7.2 Turkey Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.7.3 Israel Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.7.4 Saudi Arabia Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
6.7.5 UAE Glioblastoma Multiforme Treatment (GBM) Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Glioblastoma Multiforme Treatment (GBM) Major Product Offerings
7.1.4 Merck Glioblastoma Multiforme Treatment (GBM) Revenue in Global Market (2017-2022)
7.1.5 Merck Key News
7.2 Teva Pharmaceutical
7.2.1 Teva Pharmaceutical Corporate Summary
7.2.2 Teva Pharmaceutical Business Overview
7.2.3 Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Major Product Offerings
7.2.4 Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Revenue in Global Market (2017-2022)
7.2.5 Teva Pharmaceutical Key News
7.3 Arbor Pharmaceuticals
7.3.1 Arbor Pharmaceuticals Corporate Summary
7.3.2 Arbor Pharmaceuticals Business Overview
7.3.3 Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Major Product Offerings
7.3.4 Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Revenue in Global Market (2017-2022)
7.3.5 Arbor Pharmaceuticals Key News
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Corporate Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Major Product Offerings
7.4.4 Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Revenue in Global Market (2017-2022)
7.4.5 Sun Pharmaceutical Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Glioblastoma Multiforme Treatment (GBM) Major Product Offerings
7.5.4 Roche Glioblastoma Multiforme Treatment (GBM) Revenue in Global Market (2017-2022)
7.5.5 Roche Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Glioblastoma Multiforme Treatment (GBM) Market Opportunities & Trends in Global Market
Table 2. Glioblastoma Multiforme Treatment (GBM) Market Drivers in Global Market
Table 3. Glioblastoma Multiforme Treatment (GBM) Market Restraints in Global Market
Table 4. Key Players of Glioblastoma Multiforme Treatment (GBM) in Global Market
Table 5. Top Glioblastoma Multiforme Treatment (GBM) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Glioblastoma Multiforme Treatment (GBM) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Glioblastoma Multiforme Treatment (GBM) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Glioblastoma Multiforme Treatment (GBM) Product Type
Table 9. List of Global Tier 1 Glioblastoma Multiforme Treatment (GBM) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glioblastoma Multiforme Treatment (GBM) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Glioblastoma Multiforme Treatment (GBM) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Glioblastoma Multiforme Treatment (GBM) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Glioblastoma Multiforme Treatment (GBM) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Glioblastoma Multiforme Treatment (GBM) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Glioblastoma Multiforme Treatment (GBM) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Glioblastoma Multiforme Treatment (GBM) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Glioblastoma Multiforme Treatment (GBM) Product Offerings
Table 32. Merck Glioblastoma Multiforme Treatment (GBM) Revenue (US$, Mn), (2017-2022)
Table 33. Teva Pharmaceutical Corporate Summary
Table 34. Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Product Offerings
Table 35. Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Revenue (US$, Mn), (2017-2022)
Table 36. Arbor Pharmaceuticals Corporate Summary
Table 37. Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Product Offerings
Table 38. Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Revenue (US$, Mn), (2017-2022)
Table 39. Sun Pharmaceutical Corporate Summary
Table 40. Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Product Offerings
Table 41. Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Glioblastoma Multiforme Treatment (GBM) Product Offerings
Table 44. Roche Glioblastoma Multiforme Treatment (GBM) Revenue (US$, Mn), (2017-2022)
Table 1. Glioblastoma Multiforme Treatment (GBM) Market Opportunities & Trends in Global Market
Table 2. Glioblastoma Multiforme Treatment (GBM) Market Drivers in Global Market
Table 3. Glioblastoma Multiforme Treatment (GBM) Market Restraints in Global Market
Table 4. Key Players of Glioblastoma Multiforme Treatment (GBM) in Global Market
Table 5. Top Glioblastoma Multiforme Treatment (GBM) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Glioblastoma Multiforme Treatment (GBM) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Glioblastoma Multiforme Treatment (GBM) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Glioblastoma Multiforme Treatment (GBM) Product Type
Table 9. List of Global Tier 1 Glioblastoma Multiforme Treatment (GBM) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glioblastoma Multiforme Treatment (GBM) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Glioblastoma Multiforme Treatment (GBM) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Glioblastoma Multiforme Treatment (GBM) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Glioblastoma Multiforme Treatment (GBM) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Glioblastoma Multiforme Treatment (GBM) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Glioblastoma Multiforme Treatment (GBM) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Glioblastoma Multiforme Treatment (GBM) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Glioblastoma Multiforme Treatment (GBM) Product Offerings
Table 32. Merck Glioblastoma Multiforme Treatment (GBM) Revenue (US$, Mn), (2017-2022)
Table 33. Teva Pharmaceutical Corporate Summary
Table 34. Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Product Offerings
Table 35. Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Revenue (US$, Mn), (2017-2022)
Table 36. Arbor Pharmaceuticals Corporate Summary
Table 37. Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Product Offerings
Table 38. Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Revenue (US$, Mn), (2017-2022)
Table 39. Sun Pharmaceutical Corporate Summary
Table 40. Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Product Offerings
Table 41. Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Glioblastoma Multiforme Treatment (GBM) Product Offerings
Table 44. Roche Glioblastoma Multiforme Treatment (GBM) Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Glioblastoma Multiforme Treatment (GBM) Segment by Type in 2021
Figure 2. Glioblastoma Multiforme Treatment (GBM) Segment by Application in 2021
Figure 3. Global Glioblastoma Multiforme Treatment (GBM) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Glioblastoma Multiforme Treatment (GBM) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Glioblastoma Multiforme Treatment (GBM) Revenue in 2021
Figure 8. By Type - Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
Figure 12. US Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
Figure 16. Germany Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 17. France Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
Figure 24. China Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 28. India Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
Figure 30. Brazil Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
Figure 33. Turkey Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Glioblastoma Multiforme Treatment (GBM) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Glioblastoma Multiforme Treatment (GBM) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Glioblastoma Multiforme Treatment (GBM) Segment by Type in 2021
Figure 2. Glioblastoma Multiforme Treatment (GBM) Segment by Application in 2021
Figure 3. Global Glioblastoma Multiforme Treatment (GBM) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Glioblastoma Multiforme Treatment (GBM) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Glioblastoma Multiforme Treatment (GBM) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Glioblastoma Multiforme Treatment (GBM) Revenue in 2021
Figure 8. By Type - Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
Figure 12. US Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
Figure 16. Germany Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 17. France Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
Figure 24. China Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 28. India Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
Figure 30. Brazil Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Revenue Market Share, 2017-2028
Figure 33. Turkey Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Glioblastoma Multiforme Treatment (GBM) Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Glioblastoma Multiforme Treatment (GBM) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Glioblastoma Multiforme Treatment (GBM) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
